- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 9 residues within 4Å:- Chain A: Y.385, L.404, D.406, A.408, V.429, N.431, H.453
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.1
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.429
NAG-NAG.3: 4 residues within 4Å:- Chain C: N.50, T.51, S.54, Q.78
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 9 residues within 4Å:- Chain C: Y.385, L.404, D.406, A.408, V.429, N.431, H.453
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.4, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.4
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.4: 22 residues within 4Å:- Chain C: K.333, G.334, S.358, H.359, N.382, S.384, Y.385, L.404, D.406
- Chain D: F.63, D.65, Y.78, S.79, Y.80, P.81, E.84, Y.126, E.128, N.129, R.130
- Ligands: NAG-NAG.5, NAG-NAG.5
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:E.128, D:N.129
- Water bridges: D:R.130, C:Y.385
- 1 x CU: COPPER (II) ION(Non-covalent)
- 15 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 8 residues within 4Å:- Chain A: L.176, A.179, T.180, N.181, L.182, A.202, V.203, F.204
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:A.179, A:L.182, A:V.203
- Water bridges: A:N.181
GOL.8: 6 residues within 4Å:- Chain A: N.335, K.337, H.359, D.360, D.361
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.1
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.337, A:D.361
- Water bridges: A:D.361, A:D.361
GOL.9: 5 residues within 4Å:- Chain A: G.525, S.547, Q.548, Q.549, K.578
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.578, A:K.578
GOL.10: 4 residues within 4Å:- Chain A: H.509, N.510, S.532, H.534
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.532
GOL.11: 4 residues within 4Å:- Chain A: H.434, Q.457, F.485
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.1
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:H.434
GOL.17: 5 residues within 4Å:- Chain A: F.61, T.85, V.87, F.111
- Chain B: R.96
7 PLIP interactions:5 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.96
- Water bridges: B:D.58, B:D.58, B:D.58, B:D.58, A:T.85, A:T.85
GOL.18: 7 residues within 4Å:- Chain A: I.113, G.137, D.159, Q.161, N.185
- Chain B: G.94, R.96
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Water bridges: A:G.137, A:D.159, A:D.159
- Hydrogen bonds: B:R.96, B:R.96
GOL.19: 3 residues within 4Å:- Chain B: G.7, W.8, P.28
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.7
GOL.22: 4 residues within 4Å:- Chain C: S.489, R.511, T.513, H.534
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.489
- Water bridges: C:R.511
GOL.23: 4 residues within 4Å:- Chain C: H.453, I.480, V.482, H.504
2 PLIP interactions:2 interactions with chain C- Water bridges: C:H.504, C:H.504
GOL.24: 7 residues within 4Å:- Chain A: S.118, H.140
- Chain C: Q.114, S.138, N.162
- Chain D: R.95, Q.100
8 PLIP interactions:1 interactions with chain A, 4 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: A:S.118, D:R.95, D:Q.100, D:Y.102, C:Q.114, C:S.138, C:N.162
- Water bridges: D:R.95
GOL.27: 4 residues within 4Å:- Chain A: Y.70, W.71
- Chain C: R.66, Q.68
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:R.66, A:W.71
GOL.30: 4 residues within 4Å:- Chain C: F.61, V.87, F.111
- Chain D: R.96
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain D- Water bridges: C:T.85
- Hydrogen bonds: D:R.96
GOL.31: 7 residues within 4Å:- Chain A: S.118, S.119
- Chain C: D.237
- Chain D: S.91, Y.102, Y.103, A.104
8 PLIP interactions:4 interactions with chain D, 2 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: D:S.91, D:A.104, A:S.119, A:S.119, C:D.237
- Water bridges: D:Y.102, D:A.104, C:D.237
GOL.32: 7 residues within 4Å:- Chain A: Q.49, H.73, E.74
- Chain D: P.9, K.10, H.11
- Ligands: NAG.14
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:E.74, A:E.74, A:E.74, D:H.11
- Water bridges: A:E.74
- 13 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 2 residues within 4Å:- Chain A: V.13, N.14
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.13
- Hydrogen bonds: A:N.14
NAG.13: 2 residues within 4Å:- Chain A: N.33, R.55
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.33
NAG.14: 5 residues within 4Å:- Chain A: N.50, T.51, S.54, Q.78
- Ligands: GOL.32
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.50, A:Q.78
NAG.15: 5 residues within 4Å:- Chain A: N.224, S.225, T.226, E.253, S.255
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.224
NAG.16: 4 residues within 4Å:- Chain A: E.347, N.348, E.350, N.374
3 PLIP interactions:3 interactions with chain A- Water bridges: A:S.376, A:S.376, A:S.376
NAG.20: 4 residues within 4Å:- Chain B: S.74, I.75, L.76, N.77
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.74, B:S.74, B:N.77
- Water bridges: B:N.77
NAG.21: 3 residues within 4Å:- Chain B: C.26, L.122, N.137
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.122
- Hydrogen bonds: B:N.137
NAG.25: 1 residues within 4Å:- Chain C: N.14
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.14
NAG.26: 3 residues within 4Å:- Chain C: G.29, N.33, R.55
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.33
- Water bridges: C:S.54, C:R.55
NAG.28: 5 residues within 4Å:- Chain C: N.224, S.225, T.226, E.253, S.255
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.224
NAG.29: 3 residues within 4Å:- Chain C: E.347, E.350, N.374
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:E.347
- Water bridges: C:S.376
NAG.33: 3 residues within 4Å:- Chain D: S.74, I.75, N.77
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.74, D:S.74, D:N.77
NAG.34: 3 residues within 4Å:- Chain D: K.10, Q.24, N.137
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Q.24
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohto, U. et al., Crystal Structures of Mouse and Human RP105/MD-1 Complexes Reveal Unique Dimer Organization of the Toll-Like Receptor Family. J.Mol.Biol. (2011)
- Release Date
- 2011-11-09
- Peptides
- CD180 antigen: AC
Lymphocyte antigen 86: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 15 x GOL: GLYCEROL(Non-functional Binders)
- 13 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ohto, U. et al., Crystal Structures of Mouse and Human RP105/MD-1 Complexes Reveal Unique Dimer Organization of the Toll-Like Receptor Family. J.Mol.Biol. (2011)
- Release Date
- 2011-11-09
- Peptides
- CD180 antigen: AC
Lymphocyte antigen 86: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D